BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Balaban DV, Marin FS, Manucu G, Zoican A, Ciochina M, Mina V, Patoni C, Vladut C, Bucurica S, Costache RS, Ionita-Radu F, Jinga M. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. World J Clin Oncol 2022; 13(7): 630-640 [PMID: 36157158 DOI: 10.5306/wjco.v13.i7.630]
URL: https://www.wjgnet.com/2218-4333/full/v13/i7/630.htm
Number Citing Articles
1
Cătălina Vlăduţ, Dana Bilous, Mihai Ciocîrlan. Real-Life Management of Pancreatic Cysts: Simplified Review of Current GuidelinesJournal of Clinical Medicine 2023; 12(12): 4020 doi: 10.3390/jcm12124020
2
Dong-Qin Xia, Yong Zhou, Shuang Yang, Fang-Fei Li, Li-Ya Tian, Yan-Hua Li, Hai-Yan Xu, Cai-Zhi Xiao, Wei Wang. Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinomaWorld Journal of Gastrointestinal Oncology 2024; 16(3): 798-809 doi: 10.4251/wjgo.v16.i3.798
3
Alex Barenboim, Diego Mercer, Kapil Sahnan, Alex Gaffan, Or Goren, Sharon Halperin, Eli Brazowski, Sharon Pelles Avraham, Joseph M. Klausner, Nir Lubezky. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOXJournal of Clinical Medicine 2024; 13(17): 5206 doi: 10.3390/jcm13175206